fda tirzepatide shortage update today The says the Zepbound is over. That's rattling the weight loss industry FDA makes end of Zepbound,

Focus on Delivery: If you choose to supplement, prioritize liposomal delivery to ensure absorption

The skin barrier prevents most applied substances from reaching deeper layers where fibroblasts reside

Ongoing safety monitoring should include periodic checks of thyroid function, gallbladder health, and kidney markers, especially for patients with pre-existing metabolic conditions

The study published in Obesity Science and Practice that Jay referenced in our conversation found that 81% of employees had a worse perception of their employer after losing GLP-1 coverage, and 18% considered finding a new job as a direct result

Reports show a fourfold increase in side effects as we get older